Neuropeptide modulation of chemically induced skin irritation.
This study addresses the hypothesis that the early symptoms of chemically induced skin irritation are neurally mediated. Several approaches were used to affect nerve transmission in adult Balb/c female mice. These included general anesthesia (i.e., sodium pentobarbital), systemic capsaicin treatment, and pretreatment with specific pharmacological antagonists of the neuropeptides substance P (SP) and neurokinin A (NKA). After these treatments, a strongly irritating dose of dinitrofluorobenzene (DNFB) was applied to the ear and its swelling was measured over several postexposure times as an index of tissue irritation. Ear swelling in Nembutal (30 mg/kg)-anesthetized mice was depressed 62 and 76% at 4 and 24 hr postexposure compared to DNFB-treated unanesthetized animals measured at the same time points. Multiple injections of capsaicin (cumulative dose 30 mg/kg) depressed DNFB-ear swelling relative to non-capsaicin, DNFB-treated controls by 15, 40 (ip), and 44 and 43% (sc) at 4 and 24 hr postexposure, respectively. In mice exposed to acute or multiple injections of the SP antagonist CP-96,345 before DNFB application, ear swelling was depressed (relative to DNFB-treated animals) by 64 and 36% (acute, sc, 10 mg/kg) and 91 and 88% (multiple, ip, cumulative 35 mg/kg) at 0.5 and 1 hr postexposure, respectively. Mice exposed to the NKA antagonist, SR 48968, alone and in combination with the SP antagonist CP-96,345 were also examined after DNFB application. Ear swelling was diminished in mice pretreated with the NKA antagonist (1.0 mg/kg) by 17, 24, 34, and 40% at 0.5, 1, 4, and 24 hr postexposure. When used in combination with the SP antagonist, DNFB-induced ear swelling was reduced by 95% compared to unantagonized, DNFB-exposed mice at the 0.5- and 1-hr time points and remained significantly depressed by 33 and 46% at 4 and 24 hr postexposure. Taken in concert, these data suggest that neuropeptides, especially the tachykinins SP and NKA, modulate the early stages of chemically induced skin irritation.
Veronesi
B
B
U.S. Environmental Protection Agency, National Health and Environmental Effects Research Laboratory, Research Triangle Park, North Carolina 27711, USA.
Sailstad
D M
DM
Doerfler
D L
DL
Selgrade
M
M
D000279:Administration, Cutaneous; D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D001713:Biphenyl Compounds / Q000494:pharmacology; D002211:Capsaicin / Q000494:pharmacology; D003877:Dermatitis, Contact / Q000209:etiology* / Q000473:pathology; D004139:Dinitrofluorobenzene / Q000008:administration & dosage / Q000633:toxicity; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004431:Ear, External; D005260:Female; D007509:Irritants / Q000633:toxicity; D051379:Mice; D008807:Mice, Inbred BALB C; D015288:Neurokinin A / Q000037:antagonists & inhibitors; D009479:Neuropeptides / Q000037:antagonists & inhibitors / Q000502:physiology*; D010880:Piperidines / Q000494:pharmacology; D012867:Skin / Q000473:pathology; D013373:Substance P / Q000037:antagonists & inhibitors; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology
D001549:Benzamides; D001713:Biphenyl Compounds; D007509:Irritants; D009479:Neuropeptides; D010880:Piperidines; D013373:Substance P; C073839:SR 48968; D015288:Neurokinin A; D004139:Dinitrofluorobenzene; D002211:Capsaicin; C066892:CP 96345